Adjuvant for vaccine immunotherapy of cancer - focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity
出版年份 2015 全文链接
标题
Adjuvant for vaccine immunotherapy of cancer - focusing on Toll-like receptor 2 and 3 agonists for safely enhancing antitumor immunity
作者
关键词
-
出版物
CANCER SCIENCE
Volume 106, Issue 12, Pages 1659-1668
出版商
Wiley
发表日期
2015-09-23
DOI
10.1111/cas.12824
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- Innate Immune Pattern Recognition: A Cell Biological Perspective
- (2015) Sky W. Brubaker et al. Annual Review of Immunology
- Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling
- (2015) Akira Maruyama et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The Translocon Protein Sec61 Mediates Antigen Transport from Endosomes in the Cytosol for Cross-Presentation to CD8+ T Cells
- (2015) Matthias Zehner et al. IMMUNITY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Links between recognition and degradation of cytoplasmic viral RNA in innate immune response
- (2015) Hiroyuki Oshiumi et al. REVIEWS IN MEDICAL VIROLOGY
- Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
- (2015) Misako Matsumoto et al. Nature Communications
- PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo
- (2015) R. Takemura et al. Cancer Immunology Research
- Dectin-2 Is a Direct Receptor for Mannose-Capped Lipoarabinomannan of Mycobacteria
- (2014) Akiko Yonekawa et al. IMMUNITY
- TRAM Is Required for TLR2 Endosomal Signaling to Type I IFN Induction
- (2014) Julianne Stack et al. JOURNAL OF IMMUNOLOGY
- Molecular Mechanisms of TLR2-Mediated Antigen Cross-Presentation in Dendritic Cells
- (2014) K.-Y. Shen et al. JOURNAL OF IMMUNOLOGY
- INAM Plays a Critical Role in IFN-γ Production by NK Cells Interacting with Polyinosinic-Polycytidylic Acid–Stimulated Accessory Cells
- (2014) Jun Kasamatsu et al. JOURNAL OF IMMUNOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Characterization of the Receptors for Mycobacterial Cord Factor in Guinea Pig
- (2014) Kenji Toyonaga et al. PLoS One
- Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
- (2014) Austin Pantel et al. PLOS BIOLOGY
- Targeting TLR3 with no RIG-I/MDA5 activation is effective in immunotherapy for cancer
- (2013) Tsukasa Seya et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Cutting Edge: IL-12 and Type I IFN Differentially Program CD8 T Cells for Programmed Death 1 Re-expression Levels and Tumor Control
- (2013) M. Y. Gerner et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Confer Tumor-Suppressive Functions on Natural Killer Cells via Polyinosinic:Polycytidylic Acid Treatment in Mouse Tumor Models
- (2013) Hiroaki Shime et al. Journal of Innate Immunity
- Toll-like receptor 3 recognizes incomplete stem structures in single-stranded viral RNA
- (2013) Megumi Tatematsu et al. Nature Communications
- Activation of Innate Immunity Is Required for Efficient Nuclear Reprogramming
- (2012) Jieun Lee et al. CELL
- Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients
- (2012) P. Sabbatini et al. CLINICAL CANCER RESEARCH
- Nucleic Acid-Sensing Toll-like Receptors Are Essential for the Control of Endogenous Retrovirus Viremia and ERV-Induced Tumors
- (2012) Philipp Yu et al. IMMUNITY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors
- (2012) H. Shime et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting pattern recognition receptors in cancer immunotherapy
- (2012) Nadège Goutagny et al. Targeted Oncology
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+dendritic cells
- (2012) Masahiro Azuma et al. OncoImmunology
- TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
- (2011) B. Salaun et al. CANCER RESEARCH
- Direct Effects of Type I Interferons on Cells of the Immune System
- (2011) S. Hervas-Stubbs et al. CLINICAL CANCER RESEARCH
- A New Subset of CD103+CD8 + Dendritic Cells in the Small Intestine Expresses TLR3, TLR7, and TLR9 and Induces Th1 Response and CTL Activity
- (2011) K. Fujimoto et al. JOURNAL OF IMMUNOLOGY
- DNA released from dying host cells mediates aluminum adjuvant activity
- (2011) Thomas Marichal et al. NATURE MEDICINE
- Opposing Effects of Toll-like Receptor (TLR3) Signaling in Tumors Can Be Therapeutically Uncoupled to Optimize the Anticancer Efficacy of TLR3 Ligands
- (2010) R. Conforti et al. CANCER RESEARCH
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Human CD141+(BDCA-3)+dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
- (2010) Sarah L. Jongbloed et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Identification of a polyI:C-inducible membrane protein that participates in dendritic cell–mediated natural killer cell activation
- (2010) Takashi Ebihara et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Characterization of human DNGR-1+BDCA3+leukocytes as putative equivalents of mouse CD8α+dendritic cells
- (2010) Lionel Franz Poulin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
- (2010) Masahiro Azuma et al. PLoS One
- CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists
- (2010) Joselín Hernández-Ruiz et al. PLoS Neglected Tropical Diseases
- Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
- (2009) Eri Ishikawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Poly I:C-Induced Activation of NK Cells by CD8 + Dendritic Cells via the IPS-1 and TRIF-Dependent Pathways
- (2009) T. Miyake et al. JOURNAL OF IMMUNOLOGY
- Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
- (2009) Sunhwa Kim et al. NATURE
- Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: A case-control study
- (2009) Ken Kodama et al. SURGERY TODAY
- Activation of Toll-like receptor 2 by a novel preparation of cell wall skeleton from Mycobacterium bovis BCG Tokyo (SMP-105) sufficiently enhances immune responses against tumors
- (2008) Masashi Murata CANCER SCIENCE
- Hepatitis C virus–infected hepatocytes extrinsically modulate dendritic cell maturation to activate T cells and natural killer cells
- (2008) Takashi Ebihara et al. HEPATOLOGY
- RNA-based viral immunity initiated by the Dicer family of host immune receptors
- (2008) Roghiyh Aliyari et al. IMMUNOLOGICAL REVIEWS
- ATP drives lamina propria TH17 cell differentiation
- (2008) Koji Atarashi et al. NATURE
- Macrophage polarization in tumour progression
- (2008) Antonio Sica et al. SEMINARS IN CANCER BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started